CA
NZ
UK
AU
IND
US
● It was grouped with Entegris and Monolithic Power among soaring chip stocks.
● It compares with a $110.4 million loss a year earlier.
● The stock traded at $142.07 on the ticker bar.
● No company-specific announcement explained the move.
● Monday's rally recovered part of that damage.
● The full-year forecast rose to $198.2 million to $200.7 million.
● Treace Medical is a medical device maker.
● Hold is not a call for the shares to outperform.
● The upgrade signals a less bearish view, not a bullish one.
● No company-specific news explained the move.
Please wait processing your request...